Announcements Trials
Browse Landscape

Phase

Phase 2/3 3Phase 3 1Phase 2 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Breast Neoplasms 11Neoplasms 5Depression 3Weight Loss 2Polycystic Ovary Syndrome 2Parasomnias 2Pain 2Lung Neoplasms 2Fatigue 2Cachexia 2Anxiety Disorders 2Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Sleep Wake Disorders 1Sleep Disorders, Circadian Rhythm 1Relapsed Malignant Solid Tumor 1Radiodermatitis 1Quality of Life 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Leukoplakia, Oral 1Keratosis, Actinic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Female Breast Cancer 1Delirium 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer - Female 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Melatonin × Clear all
NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT02454855 2022-06-13

MEQAPAG

Centre Jean Perrin

Phase 3 Terminated
123 enrolled
Tumor-Agnostic

Neoplasms

NCT00925899 2017-04-20

Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer

Bispebjerg Hospital

Phase 2/3 Completed
72 enrolled 11 charts

Fatigue, Neoplasms

NCT02200172 2016-07-19

The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study

Bruyère Health Research Institute.

Phase 2 Completed
60 enrolled

Delirium, Neoplasms

NCT01706627 2012-10-15

MIRCIT

Khon Kaen University

Phase 2/3 Completed
175 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡